Literature DB >> 27233233

Acidic tumor microenvironment in human melanoma.

Ines Böhme1, Anja Katrin Bosserhoff2,3.   

Abstract

One characteristic of solid tumors such as malignant melanoma is the acidification of the tumor microenvironment. The deregulation of cancer cell metabolism is considered a main cause of extracellular acidosis. Here, cancer cells utilize aerobic glycolysis instead of oxidative phosphorylation even under normoxic conditions, as originally described by Otto Warburg. These metabolic alterations cause enhanced acid production, especially of lactate and carbon dioxide (CO2 ). The extensive production of acidic metabolites and the enhanced acid export to the extracellular space cause a consistent acidification of the tumor microenvironment, thus promoting the formation of an acid-resistant tumor cell population with increased invasive and metastatic potential. As melanoma is one of the deadliest and most metastatic forms of cancer, understanding the effects of this extracellular acidosis on human melanoma cells with distinct metastatic properties is important. The aim of this review was to summarize recent studies of the acidification of the tumor microenvironment, focusing on the specific effects of the acidic milieu on melanoma cells and to give a short overview of therapeutic approaches.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Cancer; acidic microenvironment; acidosis; malignant phenotype; melanoma

Mesh:

Year:  2016        PMID: 27233233     DOI: 10.1111/pcmr.12495

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  33 in total

Review 1.  Acidosis and cancer: from mechanism to neutralization.

Authors:  Arig Ibrahim-Hashim; Veronica Estrella
Journal:  Cancer Metastasis Rev       Date:  2019-06       Impact factor: 9.264

2.  Colorectal cancer extracellular acidosis decreases immune cell killing and is partially ameliorated by pH-modulating agents that modify tumor cell cytokine profiles.

Authors:  Kelsey E Huntington; Anna Louie; Lanlan Zhou; Attila A Seyhan; Aaron Wp Maxwell; Wafik S El-Deiry
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

Review 3.  Nanozyme-Based Enhanced Cancer Immunotherapy.

Authors:  Ngoc Man Phan; Thanh Loc Nguyen; Jaeyun Kim
Journal:  Tissue Eng Regen Med       Date:  2022-01-31       Impact factor: 4.169

4.  Synthesis and characterization of a novel pH-responsive drug-releasing nanocomposite hydrogel for skin cancer therapy and wound healing.

Authors:  Andrea Gonsalves; Pranjali Tambe; Duong Le; Dheeraj Thakore; Aniket S Wadajkar; Jian Yang; Kytai T Nguyen; Jyothi U Menon
Journal:  J Mater Chem B       Date:  2021-12-01       Impact factor: 6.331

Review 5.  Dual-Mode Tumor Imaging Using Probes That Are Responsive to Hypoxia-Induced Pathological Conditions.

Authors:  S A Amali S Subasinghe; Robia G Pautler; Md Abul Hassan Samee; Jason T Yustein; Matthew J Allen
Journal:  Biosensors (Basel)       Date:  2022-06-30

6.  Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.

Authors:  Yan Qu; Shuqing Zhang; Yan Zhang; Xien Feng; Fengjuan Wang
Journal:  Virchows Arch       Date:  2020-11-12       Impact factor: 4.064

Review 7.  How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance.

Authors:  Anja Wessely; Theresa Steeb; Carola Berking; Markus Vincent Heppt
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 8.  Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape.

Authors:  Veronica Romano; Immacolata Belviso; Alessandro Venuta; Maria Rosaria Ruocco; Stefania Masone; Federica Aliotta; Giuseppe Fiume; Stefania Montagnani; Angelica Avagliano; Alessandro Arcucci
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

9.  Traceable metallic antigen release for enhanced cancer immunotherapy.

Authors:  Fangfang Lv; Yan Jin; Xiaochen Feng; Miao Fan; Cui Ren; Xinyue Dai; Jinchao Zhang; Zhenhua Li; Yi Jin; Huifang Liu
Journal:  J Nanopart Res       Date:  2021-06-14       Impact factor: 2.253

Review 10.  Membrane Transporters and Channels in Melanoma.

Authors:  Ines Böhme; Roland Schönherr; Jürgen Eberle; Anja Katrin Bosserhoff
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.